Approaches to a center‐specific CSF amyloid ratio cutoff based on PET‐amyloid positivity at the Wake Forest Alzheimer's Disease Research Center

Abstract

Background: Variation in demographics and regional influences on AD suggest a need for ADRC center‐specific biomarker cutoffs. The Wake Forest ADRC has a unique community‐based cohort from a recruitment area with high rates of metabolic disease and hypertension.